13.03.2014 Views

XXII. BIOCHEMICKÝ ZJAZD - Jesseniova lekárska fakulta

XXII. BIOCHEMICKÝ ZJAZD - Jesseniova lekárska fakulta

XXII. BIOCHEMICKÝ ZJAZD - Jesseniova lekárska fakulta

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Posters<br />

11.<br />

DESIGN of an EXPrESSION SYSTEM for THE PRODUCTION OF<br />

RECOMBINANT HUMAN THROMBIN IN ESCherICHIA COLI<br />

Michaela Kandričáková 1 , Stanislav Stuchlík1 and Ján Turňa 1,2<br />

1<br />

Comenius University, Faculty of Natural Sciences, Department of Molecular Biology,<br />

2<br />

Department of Molecular Biology SAV Bratislava<br />

Thrombin is a plasmatic protease, which plays a key role in blood coagulation. This form of<br />

active prothrombin is characterised by many biological functions including procoagulation<br />

and anti coagulation effects. The polyfunctionality of thrombin has received increasing<br />

interest in biofarmaceutical and biomedical research. One of the possible ways to gain<br />

recombinant human thrombin is to use expression systems based on E.coli cells. E.coli<br />

offers many adventages over other host organisms and therefore remains the most<br />

commonly used host for the production of heterologous proteins. Prethrombin-2, an<br />

activation intermediate of thrombin, is often expressed as a precursor of prothrombin.<br />

Presumably, the use of this gene assures higher transcription and translation efficiency<br />

compared to prothrombin gene mainly because of the smaller size of the mRNA transcript.<br />

During the preparation of prethrombin-2 syntetic gene the known sequence will be used<br />

with optimized E.coli codon usage ensuring higher expression yields.<br />

The aim of this work is the design of proper expression system for the production of<br />

recombinant human thrombin in the E.coli host cells. The study is focused on selection of<br />

proper gene sequence with codon usage optimized for E.coli, selection of suitable expression<br />

system and in the next step we would like to optimise physiological conditions for the<br />

foreign protein expression and subsequent verify expression of recombinant thrombin.<br />

126 <strong>XXII</strong>. Biochemistry Congress, Martin

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!